SCHEMBL23748846

SCHEMBL23748846

O=C(OCCl)C1(c2ccccc2)CCCC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APOBEC3A P31941 3/20 0.61
▸ APOBEC3G Q9HC16 3/20 0.61
▸ SIGMAR1 Q99720 4/20 0.59
▸ PRCP P42785 3/20 0.59
▸ MEN1 O00255 3/20 0.59
▸ KMT2A Q03164 3/20 0.59
▸ ALDH1A1 P00352 4/20 0.58
▸ MAPK1 P28482 1/20 0.58
▸ GAA P10253 1/20 0.58
▸ POLB P06746 1/20 0.58
▸ AKR1C1 Q04828 1/20 0.58
▸ HTT P42858 2/20 0.57
▸ CYP1A2 P05177 2/20 0.54
▸ CYP3A4 P08684 2/20 0.54
▸ CYP2D6 P10635 2/20 0.54
▸ TMEM97 Q5BJF2 2/20 0.54
▸ CHRM2 P08172 2/20 0.54
▸ CHRM1 P11229 2/20 0.54
▸ SLC22A1 O15245 2/20 0.54
▸ KDM4E B2RXH2 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23748814 0.98 MAPK1 (0.60) APOBEC3AAPOBEC3GSIGMAR1PRCPMEN1
SCHEMBL23748809 0.93 OPRM1 (0.56) APOBEC3AAPOBEC3GSIGMAR1PRCPMEN1
SCHEMBL6660823 0.83 OPRM1 (0.75) APOBEC3AAPOBEC3GSIGMAR1PRCPALDH1A1
SCHEMBL23225664 0.82 OPRM1 (0.73) APOBEC3AAPOBEC3GSIGMAR1PRCPALDH1A1
SCHEMBL329509 0.80 AKR1C1 (0.68) APOBEC3AAPOBEC3GSIGMAR1PRCPMEN1
SCHEMBL23225663 0.80 OPRM1 (0.75) APOBEC3AAPOBEC3GSIGMAR1PRCPALDH1A1
SCHEMBL24131750 0.80 APOBEC3A (0.60) APOBEC3AAPOBEC3GSIGMAR1PRCPMEN1
SCHEMBL9961316 0.79 APOBEC3A (0.63) APOBEC3AAPOBEC3GSIGMAR1PRCPMEN1
SCHEMBL27101945 0.78 APOBEC3A (0.59) APOBEC3AAPOBEC3GSIGMAR1PRCPMEN1
SCHEMBL1041983 0.77 AKR1C1 (0.63) APOBEC3AAPOBEC3GSIGMAR1PRCPMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3863629-A1 PRODRUGS OF CGRP ANTAGONISTS Biohaven Pharmaceutical Holding Company Ltd. (US) 2021-08-18 — — EP disclosed
Send feedback